BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 7, 2026
Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Questcor Raises $5M To Fund $18.2M Purchase Of Nascobal

June 18, 2003
By Aaron Lorenzo

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

NPS Planning To Sell $125M In Notes After Merger Talks End

June 12, 2003
By Aaron Lorenzo
View All Articles by Aaron Lorenzo

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 6, 2026.
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • University of Southern California reports new MAPT aggregation inhibitors

    BioWorld Science
    The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing